Objective—Current antiplatelet strategies to prevent myocardial infarction and stroke are
limited by bleeding risk. A better understanding of the roles of distinct platelet-activating …

Background Cardiovascular disease (CVD) is the most prevalent complication of type 2
diabetes with an estimated 65% of people with type 2 diabetes dying from a cause related to …

Dual antiplatelet therapy with a thienopyridine in combination with aspirin for 1 to 6 months
after stenting has been recommended by the manufacturers to reduce ischemic …

Background Dual antiplatelet therapy (DAPT) is a mainstay treatment for hospital survivors
of an acute myocardial infarction (AMI). However, there are limited data on the prescribing …

Objective. To evaluate the effect of various antithrombotic treatment regimens on the
incidence of hemorrhagic complications that occur in the perioperative period in patients …

Las enfermedades tromboembólicas siguen siendo una de las causas más importantes de
morbilidad y mortalidad en todo el mundo. El mecanismo fisiopatológico subyacente en los …

Evidences about combination use of acetylsalicylic acid (aspirin) and clopidogrel in acute
coronary syndrome SciELO - Scientific Electronic Library Online vol.58 número1 Mutación c.3037G>A …

Сердечно-сосудистые заболевания (ССЗ) по-прежнему остаются основной причиной
инвалидизации и смертности по всему миру–ежегодно умирает около 17 млн. человек …

Objective CHARISMA was a landmark randomized clinical trial that failed to demonstrate a
benefit of dual anti-platelet therapy (DAPT) in preventing cardiovascular events in the overall …

P2Y12 antagonists are pharmacological agents used clinically in advanced stages of
coronary artery disease in order to inhibit ADP-induced activation and aggregation of …